• SPX
  • $5,699.94
  • -0.17 %
  • -$9.60
  • DJI
  • $42,011.59
  • -0.44 %
  • -$184.93
  • N225
  • $38,552.06
  • 1.97 %
  • $743.30
  • FTSE
  • $8,282.52
  • -0.1 %
  • -$8.34
  • IXIC
  • $17,918.48
  • -0.04 %
  • -$6.65
Sonnet BioTherapeutics Holdings, Inc. (SONN) Earning

Sonnet BioTherapeutics Holdings, Inc. (SONN) Earning

NASDAQ Currency in USD Disclaimer

Stock Price

$5.16

-$0.45

(-7.95%)

Day's range
$5.01
Day's range
$5.9

Sonnet BioTherapeutics Holdings, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 0 -$5.60 -$5.60 -$5.60
Q2 2024 0 -$6.12 -$6.12 -$6.12
Q3 2024 2 -$5.52 -$4.56 -$5.04
Q4 2024 0 -$4.16 -$4.16 -$4.16
Q1 2025 1 -$4.08 -$4.08 -$4.08
Q2 2025 1 -$3.36 -$3.36 -$3.36
Q3 2025 1 -$3.36 -$3.36 -$3.36

Sonnet BioTherapeutics Holdings, Inc. Earnings Date And Information

Sonnet BioTherapeutics Holdings, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-5.6 earnings per share for the quarter, missing analysts' consensus estimates of $-0.76 by $4.84. The company had revenue of 0 for the quarter and had revenue of 147,805 for the year. Sonnet BioTherapeutics Holdings, Inc. has generated $-18 earnings per share over the last year ($-18.14 diluted earnings per share) and currently has a price-to-earnings ratio of -3.25. Sonnet BioTherapeutics Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 12th, 2024 based on prior year's report dates.

Sonnet BioTherapeutics Holdings, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/14/2024 Q3 2024 -$0.76 -$0.70 0.06 $28,500 $0
05/14/2024 Q2 2024 $0.14 $0.08 -0.06 $0
02/14/2024 Q1 2024 -$0.90 -$0.31 0.59 $18,626
12/14/2023 Q4 2023 -$2.09 $31,100 $37,255
08/14/2023 Q3 2023 -$0.31 -$2.96 -2.65 $20,000 $36,850
05/10/2023 Q2 2023 -$0.49 -$7.56 -7.07 $36,445
02/13/2023 Q1 2023 -$1.10 -$17.40 -16.3 $37,255
12/15/2022 Q4 2022 -$1.51 -$37.19 -35.68 $100,000 $62,753
08/15/2022 Q3 2022 -$1.96 -$40.07 -38.11 $50,000 $62,071
05/10/2022 Q2 2022 -$1.68 -$41.92 -40.24 $95,320
02/08/2022 Q1 2022 -$92.34 -$31.53 60.81 $129,799
12/16/2021 Q4 2021 -$3.08 -$53.88 -50.8 $483,626
08/16/2021 Q3 2021 -$83.71 $0
05/17/2021 Q2 2021 -$99.24 $0
02/16/2021 Q1 2021 -$105.13 $0
12/17/2020 Q4 2020 -$153.11 $12.74 M $-5,681,238
08/14/2020 Q3 2020 -$322.10 $12.73 M $0
05/18/2020 Q2 2020 -$103.47 $5.68 M
03/18/2020 Q1 2020 -$136.00 $0
11/14/2019 Q4 2019 -$4,457.61 $10.87 M $9.65 M
 

Sonnet BioTherapeutics Holdings, Inc. Earnings: Frequently Asked Questions

  • When is Sonnet BioTherapeutics Holdings, Inc.'s earnings date?

    Sonnet BioTherapeutics Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 12th, 2024 based off last year's report dates.

  • How can I listen to Sonnet BioTherapeutics Holdings, Inc.'s earnings conference call?

    The conference call for Sonnet BioTherapeutics Holdings, Inc.'s latest earnings report can be listened to online.

  • How can I read Sonnet BioTherapeutics Holdings, Inc.'s conference call transcript?

    The conference call transcript for Sonnet BioTherapeutics Holdings, Inc.'s latest earnings report can be read online.

  • How much revenue does Sonnet BioTherapeutics Holdings, Inc. generate each year?

    Sonnet BioTherapeutics Holdings, Inc. (:SONN) has a recorded annual revenue of $147,805.

  • How much profit does Sonnet BioTherapeutics Holdings, Inc. generate each year?

    Sonnet BioTherapeutics Holdings, Inc. (:SONN) has a recorded net income of $147,805. Sonnet BioTherapeutics Holdings, Inc. has generated $-18.14 earnings per share over the last four quarters.

  • What is Sonnet BioTherapeutics Holdings, Inc.'s price-to-earnings ratio?

    Sonnet BioTherapeutics Holdings, Inc. (:SONN) has a price-to-earnings ratio of -3.25 and price/earnings-to-growth ratio is -0.04.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.